A compound which is an antagonist of platelet activating factor (PAF-antagonist) or a structurally related compound thereof not having PAF-antagonistic activity can be used for decreasing the plasma level of lipoprotein(a) and/or increasing the plasma level of high-density lipoprotein. The compound may be an azepine derivative, especially a benzo- or thienotriazolo-diazepine derivative, a diphenyl-tetrahydrofuran or diphenyldioxolane derivative or a tetrahydrofuran phospholipid analogue.
血小板活化因子拮抗剂(PAF-antagonist)化合物或其结构相关的不具有 PAF 拮抗活性的化合物可用于降低血浆中脂蛋白(a)的
水平和/或提高血浆中高密度脂蛋白的
水平。该化合物可以是氮杂卓衍
生物,特别是苯并三唑或
噻吩三唑-二氮杂卓衍
生物、二苯基
四氢呋喃或二苯基二
氧戊环衍
生物或
四氢呋喃磷脂类似物。